BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 16038664)

  • 1. Uveitis in Gaucher disease.
    Dweck A; Rozenman J; Ronen S; Zimran A; Elstein D
    Am J Ophthalmol; 2005 Jul; 140(1):146-7. PubMed ID: 16038664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uveitis in Gaucher disease.
    Roos JC
    Am J Ophthalmol; 2006 Feb; 141(2):421; author reply 421-2. PubMed ID: 16458721
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diagnosis and therapy of Gaucher disease].
    Ehlen C; Heintges T; Niederau C
    Med Klin (Munich); 1995 May; 90(5):284-90. PubMed ID: 7791695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked clinical and histologic improvement in a patient with type-1 Gaucher's disease following long-term glucocerebroside substitution. A case report and review of current diagnosis and management.
    Heukamp LC; Schröder DW; Plassmann D; Homann J; Büttner R
    Pathol Res Pract; 2003; 199(3):159-63. PubMed ID: 12812317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gaucher disease: progressive mesenteric and mediastinal lymphadenopathy despite enzyme therapy.
    Burrow TA; Cohen MB; Bokulic R; Deutsch G; Choudhary A; Falcone RA; Grabowski GA
    J Pediatr; 2007 Feb; 150(2):202-6. PubMed ID: 17236903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of bone marrow failure in Gaucher's disease with low-dose modified glucocerebrosidase.
    Mistry PK; Davies S; Corfield A; Dixon AK; Cox TM
    Q J Med; 1992 Jul; 83(303):541-6. PubMed ID: 1484931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of vision in Gaucher's disease and its reversal by enzyme-replacement therapy.
    vom Dahl S; Niederau C; Häussinger D
    N Engl J Med; 1998 May; 338(20):1471-2. PubMed ID: 9583981
    [No Abstract]   [Full Text] [Related]  

  • 8. [French results of enzyme replacement therapy in Gaucher's disease].
    Schaison G; Caubel I; Belmatoug N; Billette de Villemeur T; Saudubray JM
    Bull Acad Natl Med; 2002; 186(5):851-61; discussion 861-3. PubMed ID: 12412377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gaucher disease type 1--therapeutic results of enzyme substitution].
    Steensberg J; Nielsen KG; Brandt NJ
    Ugeskr Laeger; 1998 Jun; 160(26):3929-30. PubMed ID: 9656836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematologic response in type I Gaucher's disease after enzyme replacement therapy.
    Parco S; Bruno G; Durighello M; Giorgini R; Simeone R; Bembi B
    Haematologica; 1999 Apr; 84(4):376-7. PubMed ID: 10190956
    [No Abstract]   [Full Text] [Related]  

  • 11. [Gaucher's disease with D409H/D409H genotype. evolution with enzyme replacement therapy].
    Castelló Girona F; Domínguez Luengo C; del Toro Riera M; Chabás Bergon A
    An Esp Pediatr; 2001 Mar; 54(3):310-2. PubMed ID: 11262263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibromyalgia and Gaucher's disease.
    Brautbar A; Elstein D; Pines B; Krienen N; Hemmer J; Buskila D; Zimran A
    QJM; 2006 Feb; 99(2):103-7. PubMed ID: 16293672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study of neurological responses to treatment with macrophage-targeted glucocerebrosidase in patients with type 3 Gaucher's disease.
    Schiffmann R; Heyes MP; Aerts JM; Dambrosia JM; Patterson MC; DeGraba T; Parker CC; Zirzow GC; Oliver K; Tedeschi G; Brady RO; Barton NW
    Ann Neurol; 1997 Oct; 42(4):613-21. PubMed ID: 9382473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme replacement therapy for Gaucher's disease: the early Canadian experience.
    MacKenzie JJ; Amato D; Clarke JT
    CMAJ; 1998 Nov; 159(10):1273-8. PubMed ID: 9861225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme replacement therapy decreases hypergammaglobulinemia in Gaucher's disease.
    Deibener J; Kaminsky P; Jacob C; Dousset B; Klein M; Duc M
    Haematologica; 1998 May; 83(5):479-80. PubMed ID: 9658738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gaucher's disease and enzyme replacement therapy].
    Cornu F
    Ann Pharm Fr; 1998; 56(3):102-7. PubMed ID: 9770016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinsonism in Gaucher's disease type 1: ten new cases and a review of the literature.
    Kraoua I; Stirnemann J; Ribeiro MJ; Rouaud T; Verin M; Annic A; Rose C; Defebvre L; Réménieras L; Schüpbach M; Belmatoug N; Vidailhet M; Sedel F
    Mov Disord; 2009 Jul; 24(10):1524-30. PubMed ID: 19513999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loosening of a noncemented porous-coated anatomic femoral component in Gaucher's disease. A case report and review of literature.
    van Wellen PA; Haentjens P; Frecourt N; Opdecam P
    Acta Orthop Belg; 1994; 60(1):119-23. PubMed ID: 8171981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme-replacement therapy for Gaucher's disease.
    N Engl J Med; 1991 Dec; 325(25):1809-11. PubMed ID: 1944489
    [No Abstract]   [Full Text] [Related]  

  • 20. [Complications of Gaucher's disease].
    Modrego Pardo PJ; Garzarán G; González N; Baiges JJ; Gazulla J
    Rev Clin Esp; 1992 Oct; 191(6):311-3. PubMed ID: 1470721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.